Researchers at MIT have used artificial intelligence to design two potential new antibiotics targeting drug-resistant gonorrhea and MRSA. The AI designed the drugs atom-by-atom, successfully killing the superbugs in lab and animal tests. While years of refinement and clinical trials are needed before human use, the team believes this marks a significant advancement in antibiotic discovery, potentially launching a "second golden age" in the field. The study, published in Cell, involved training AI on millions of compounds to predict effective molecular structures, ultimately yielding two promising drug candidates.

Prepared by Olivia Bennett and reviewed by editorial team.